BERWYN, Pa., Feb. 28, 2025 /PRNewswire/ -- Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announced today a poster presentation at SECO 2025 being held from February 26 – March 2 in ...

In the years to come, Bavarian Nordic foresees that more commercially minded-business taking the lead over the sort of ...

BERWYN, Pa., Feb. 28, 2025 /PRNewswire/ -- Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announced today a poster presentation at SECO 2025 being held from February 26 – March 2 in Atlanta, ...

Newbury Pharmaceuticals is pleased to announce the successful Marketing Authorization (MA) of Macitentan Newbury in Denmark as the first country in a Scandinavian registration procedure. Approvals in ...

Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. The Danish company’s chikungunya vaccine, Vimkunya, has now crossed the FDA finish line, heating up the ...

The EC has authorised the marketing of Bavarian Nordic's Vimkunya chikungunya vaccine for individuals as young as 12 years ...

Lauritz Knudsen Electrical and Automation introduces advanced automation solutions aimed at boosting energy efficiency by 30% ...